Center-Authored Papers

Filters: Author is Delgado, David J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Vincristine
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Treatment Outcome
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Time Factors
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Risk Factors
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
RISK
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Retrospective Studies
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Prednisone
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Prednisolone
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
NEUTROPENIA
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Multivariate Analysis
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
MITOXANTRONE
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Middle Aged
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Male
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Lymphoma, Non-Hodgkin
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Kidney Diseases
Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M.  2003.  Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.. Leukemia & lymphoma. 44(12):2069-76. Abstract
Humans
Lyman GH, Delgado DJ.  2003.  Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.. Cancer. 98(11):2402-9. Abstract